SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust ($SLV) is experiencing extreme volatility due to recent CME Group margin requirement increases and impending Chinese export restrictions on silver, which are set to take effect. This has created a stark divide among traders, with many anticipating a massive short squeeze driven by perceived physical scarcity and industrial demand, while others warn of a speculative "pump and dump" and forced liquidations.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending after receiving FDA approval for NEREUS, a new treatment for motion-induced vomiting, notable for being the first in decades and for not causing drowsiness. The community is actively discussing its broader potential as an add-on therapy for GLP-1 induced nausea and vomiting, fueling significant speculation about a potential buyout from a major pharmaceutical company. This approval, coupled with other imminent regulatory decisions for jet lag and an antipsychotic drug, positions Vanda as a key topic among investors.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is a prominent topic among crypto enthusiasts, driven by its narrative as Bitcoin's "digital silver" and intense discussions around critical technical support and resistance levels. The community is actively debating a potential major price movement, with many expressing strong bullish conviction despite market consolidation and challenging any bearish sentiment.

Radware Ltd. engages in the provision of application security and delivery solutions for multi-cloud environments. The company’s cloud application, infrastructure, and API security solutions use AI-driven algorithms for precise, hands-free, real-time protection from the most sophisticated web, application, and DDoS attacks, API abuse, and bad bots. It operates through the following segments: Radware’s Core Business and Hawks’ Business. The Radware’s Core Business segment engages in providing cloud security-as-a-service products, application and data center security solutions, and application availability services. The Hawks’ Business segment provides cloud security solutions, including threat detection, entitlement management, and posture management. The company was founded by Yehuda Zisapel and Roy Zisapel on May 16, 1996 and is headquartered in Tel Aviv, Israel.

Radware

Radware is trending as its AI-powered cloud cybersecurity solutions garner attention, notably with the company's discovery of a critical zero-click AI vulnerability. Accelerated growth in cloud recurring revenue and strategic global expansions are fueling community discussions around its significant potential within the rapidly evolving threat landscape, alongside high growth expectations reflected in its valuation.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble Inc. is trending as the community highlights its deep strategic ties with Tether, including a significant ownership stake and substantial commitments for ad and cloud services. This partnership, alongside the acquisition of Northern Data AG greatly expanding Rumble's AI and cloud infrastructure, is fueling strong discussions about the stock being undervalued and ripe for a potential short squeeze given its high short interest.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences (GLSI) is trending after preliminary Phase 3 trial data showed an 80% reduction in breast cancer recurrence, reinforcing strong efficacy signals. This positive news, combined with an extended insider share lock-up and significant borrowing costs for short sellers, has ignited community discussion around the stock's undervaluation, potential for a short squeeze, and future strategic partnerships or a buyout.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

The Metals Company (TMC) is actively trending as it formally enters the U.S. regulatory process for deep-sea mining exploration licenses, highlighted by upcoming public hearings in late January. Investors are sharply divided between strong conviction in its national security importance for critical mineral supply and skepticism over its pre-revenue status and long-term production timeline, with many anticipating a rebound after recent volatility.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc. is trending amidst a notable price decline, with many attributing the sell-off to broad market pressures and potential tax loss harvesting. This has sparked a divided community perspective: while some express frustration and predict further drops, many investors view current valuations as a compelling long-term opportunity, citing strong underlying business growth, international expansion, and new services like lab testing. Community discussions are actively focused on the company's potential role in the evolving GLP-1 market and the high short interest, which could fuel a reversal.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending amid choppy, low-volume trading as market participants grapple with mixed signals from recent Fed minutes regarding future rate policy. Community discussions are sharply divided, with bulls anticipating continued strength towards new highs and bears predicting an imminent correction, particularly as the anticipated "Santa Rally" appears to be largely absent.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. It provides online news services where users can select and rank web content. The firm also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending following a significant analyst upgrade that named it a top pick and added it to a "Conviction Buy" list. Community sentiment is largely bullish, focusing on strong average revenue per user growth and the platform's valuable human-created content for AI models, with many anticipating a technical breakout. This optimism is balanced by some skepticism regarding its high valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CervoMed Inc. (NASDAQ:CRVO) Receives Average Recommendation of "Moderate Buy" from Brokerages

CervoMed Inc. (NASDAQ:CRVO - Get Free Report) has been given an average recommendation of "Moderate Buy" by the eleven analysts that are covering the company, MarketBeat.com reports. Three equities...

Matthew Winton Buys 1,500 Shares of CervoMed (NASDAQ:CRVO) Stock

CervoMed Inc. (NASDAQ:CRVO - Get Free Report) insider Matthew Winton purchased 1,500 shares of the company's stock in a transaction dated Tuesday, November 18th. The shares were bought at an average...

Sylvie Gregoire Purchases 1,707 Shares of CervoMed (NASDAQ:CRVO) Stock

CervoMed Inc. (NASDAQ:CRVO - Get Free Report) Director Sylvie Gregoire purchased 1,707 shares of the firm's stock in a transaction on Friday, November 14th. The stock was acquired at an average cost...

Insider Buying: CervoMed (NASDAQ:CRVO) CEO Buys 1,707 Shares of Stock

CervoMed Inc. (NASDAQ:CRVO - Get Free Report) CEO John Alam acquired 1,707 shares of the business's stock in a transaction on Friday, November 14th. The shares were bought at an average price of...

CervoMed (NASDAQ:CRVO) CEO John Alam Buys 4,447 Shares

CervoMed Inc. (NASDAQ:CRVO - Get Free Report) CEO John Alam acquired 4,447 shares of CervoMed stock in a transaction on Thursday, November 13th. The stock was acquired at an average cost of $7.51 per...

CervoMed (NASDAQ:CRVO) Director Sylvie Gregoire Acquires 4,447 Shares

CervoMed Inc. (NASDAQ:CRVO - Get Free Report) Director Sylvie Gregoire bought 4,447 shares of the company's stock in a transaction on Thursday, November 13th. The shares were acquired at an average...

CervoMed (NASDAQ:CRVO) Insider Matthew Winton Buys 10,000 Shares of Stock

CervoMed Inc. (NASDAQ:CRVO - Get Free Report) insider Matthew Winton bought 10,000 shares of the business's stock in a transaction on Friday, November 14th. The stock was bought at an average price...

CervoMed (NASDAQ:CRVO) Insider Purchases $75,700.00 in Stock

CervoMed Inc. (NASDAQ:CRVO - Get Free Report) insider Matthew Winton purchased 10,000 shares of the firm's stock in a transaction dated Friday, November 14th. The stock was acquired at an average...

FY2025 EPS Estimates for CervoMed Cut by Chardan Capital

CervoMed Inc. (NASDAQ:CRVO - Free Report) - Investment analysts at Chardan Capital dropped their FY2025 earnings estimates for CervoMed in a report released on Tuesday, November 11th. Chardan Capital...

Sylvie Gregoire Acquires 5,553 Shares of CervoMed (NASDAQ:CRVO) Stock

CervoMed Inc. (NASDAQ:CRVO - Get Free Report) Director Sylvie Gregoire bought 5,553 shares of CervoMed stock in a transaction dated Wednesday, November 12th. The shares were acquired at an average...

CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. The company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha. CervoMed, Inc. was founded in1995 and is headquartered in Boston, MA.

CRVO
CervoMed Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CRVO News

CRVOCervoMed Inc